27 Apr Amipro Advanced Development Products (Pty) Ltd Products
|
Company name & Address: |
Registration number |
Batch number(s) |
Expiry date |
Pack size |
First distributed |
Re-call Classification |
Recall date |
Date published |
| Amipro Advanced Development Products (Pty) Ltd. Eastgate Business Park, Unit 3 1 South Road, Corner Marlboro Drive Sandton
2090 |
N/A (Category D Products) |
Refer to Notice |
Refer to Notice |
Refer to Notice |
Refer to Notice |
Class III Type B |
4 November
2024 |
21 November 2024 |
Brief description of the problem (reason for recall)
This recall is initiated due to labels of products imported from the United States and Europe not complying with certain regulatory requirements for Complementary Medicines as expressed in the SAPHRA guidelines.
Advice for health professionals and distributors
We request that you cease all distribution, selling and / or dispensing and remove the identified product batches from stores, storage facilities and shelves.
Please quarantine the identified product batches as soon as possible and return all inventory to Amipro Advanced Development Products (Pty) Ltd before 30/11/2024.
Proposed action taken and its urgency: A SAHPRA approved recall letter was distributed to all distribution points and the recall process was initiated.
Reporting side effects
Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.